ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts (2019) 63 GP12 | DOI: 10.1530/endoabs.63.GP12

Functional mixed oncocytic adrenocortical neoplasm presenting as an asymptomatic adrenal mass

Niculina Racolta1, Sarah Homsi2, Philippe Keller3, Felix Lerintiu4, V Linder5, Bernard Goichot6 & Agnès Smagala1


1Endocrinology and Diabetes Department, Civil Hospital ’Louis Pasteur’, Colmar, France; 2Faculty of Medicine Strasbourg, Strasbourg, France; 3General Surgery Department, Civil Hospital ’Louis Pasteur’, Colmar, France; 4Pathology Department Civil Hospital ’Louis Pasteur’, Colmar, France; 5Pathology Department ‘Hautepierre’ University Hospital Strasbourg, Strasbourg, France; 6Endocrinology Department ‘Hautepierre’ University Hospital Strasbourg, Strasbourg, France.


Oncocytic adrenocortical neoplasm (OAN) represents a rare variant of adrenocortical carcinoma (ACC) with less than 150 cases reported in the literature. OANs account for 1.8% of adrenal masses, predominantly in adults and usually presenting as large tumors featuring hormonal secretion in 20% of cases. Accurate histological characterization of OANs is crucial as this subtype is believed to be more indolent in clinical behavior. There are 3 categories of OANs: pure oncocytic, mixed oncocytic and ordinary adrenocortical with focal oncocytic changes. The Weiss scoring system used for ACC overestimates malignancy in OANs, therefore alternatives like the Lin-Weiss-Bisceglia (LWB) system need to be used for proper diagnosis and subsequent evaluation of malignant potential. We report the case of a 63-year-old menopaused female with medical history of well controlled type 2 diabetes and hypertension addressed by her GP for exploration of a large adrenal mass neglected by the patient for four years. On interrogation, the patient was completely asymptomatic. Clinical examination revealed a large palpable mass in the left abdomen, normal BMI, no Cushing or virilization syndrome. Hormonal workup showed important elevation of 17OHprogesterone and DHEAS, increased D4Androstendione and total testosterone. The rest of the hormonal workup was in the normal range. Whole body CT scan was consistent with a left heterogeneous adrenal mass of 14×13.6×11 cm, 42HU spontaneous density with calcifications and necrotic areas and no adenopathy or distant metastasis. Open surgery was performed and excised a 15 cm mass weighing 1140 g. Histologic diagnosis was challenging and demanded a second opinion to finally conclude in favor of a mixed OAN with three major criteria and two minor criteria according to the LWB scoring system and a prognosis of malignant evolution. Adjuvant Mitotane treatment was started after discussion in multidisciplinary meeting. Very close clinical, hormonal and imaging follow-up is required for a minimum of 5 years. Although rare entities, OANs should be considered in the differential diagnosis of large adrenal masses. Histological examination by experienced pathologists using the LWB scoring system is of major importance in order to establish the tumor’s biologic potential and the patient’s prognosis.

Keywords: oncocytic adrenocortical neoplasm, adrenal mass

Article tools

My recent searches

No recent searches.